Additionally, tumor susceptibility assays using mice lacking both Adamts12 and Fbln2 genes would be necessary to understand in depth the significance of this interaction not only in breast cancer but also in tumors from different origins. This evidence concerns the gene ADAMTS12 and breast cancer.